1978

1979

2. Johnson L.N., Stura E.A., Wilson K.S., Sansom M.S.P., Weber I.T., (1979). Nucleotide binding to Glycogen Phosphorylase b in the crystal. Journal of Molecular Biology.134:639-653.

1980

3. Johnson LN. Jenkins JA. Wilson KS. Stura EA. Zanotti G. (1980) Proposals for the catalytic mechanism of glycogen phosphorylase b prompted by crystallographic studies on glucose 1-phosphate binding. Journal of Molecular Biology. 140:565-580.

1981

4. Jenkins JA. Johnson LN. Stuart DI. Stura EA. Wilson KS. Zanotti G. (1981) Phosphorylase: control and activity. [Review] Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences. 293:23-41.

1983

6. Stura E.A. Zanotti G. Babu Y.S. Sansom M.S. Stuart D.I. Wilson K.S. Johnson LN. Van de Werve G. (1983) Comparison of AMP and NADH binding to glycogen phosphorylase b. Journal of Molecular Biology. 170:529-565.

7. Wilson K.S., Stura E.A., Wild D.L., Todd R.J., Stuart D.I., Babu Y.S., Jenkins J.A., Standing T.S., and Johnson L.N., Fourme R., Kahn R., et al. (1983). Macromolecular Crystallography with synchrotron radiation. J. Appl. Cryst. 16:28-41.

1984

8. Sansom M.S. Babu Y.S. Hajdu J. Stuart D.I. Stura E.A. Johnson L.N. (1984) The role of pyridoxal phosphate in glycogen phosphorylase b; structure, environment and relationship to catalytic mechanism. Progress in Clinical & Biological Research. 144A, 127-146.

9. Lorek A. Wilson K.S. Sansom M.S. Stuart D.I. Stura E.A. Jenkins J.A. Zanotti G. Hajdu J. Johnson L.N. (1984) Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b. Biochemical Journal. 218:45-60.

1986

10. Wilson, I.A., Bergmann, K.F., Stura, E.A. (1986) Structural analysis of anti-peptide antibodies against influenza virus hemagglutinin. In: Vaccines'86, New Approaches to Immunization Developing Vaccines Against Parasitic, Bacterial and Viral Disease, R.A. Lerner, R. Chanock and F. Brown, eds. Cold Spring Harbor Press, New York, pp. 33-37.

1987

11. Stura E.A., Feinstein A., Wilson I.A. (1987) Crystallization and Preliminarycrystallographic data for an anti-progesterone monoclonal antibody Fab' and steroid-Fab' complexes. Journal of Molecular Biology. 193:299-231.

12. Stura E.A., Arevalo J.H., Feinstein A., Heap R.B., Taussig M.J., Wilson I.A. (1987) Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes. Immunology 62:511-521.

1988

13. Schulze-Gahmen U., Rini J.M., Arevalo J.H., Stura E.A., Kenten J.H. and Wilson I.A. (1988) Preliminary crystallographic data, primary sequence, and binding data for an anti-peptide Fab and its complex with a synthetic peptide from influenza virus hemagglutinin. Journal of Biological Chemistry 263:17100-17105.

1989

14. Stura E.A., Johnson D.L., Inglese J., Smith J.M., Benkovic S.J., Wilson I.A. (1989) Preliminary Crystallographic Investigations of Glycinamide Ribonucleotide Tranformylase. Journal of Biological Chemistry 264:9703-9706.

15. Lambert G., Stura E.A., Wilson I.A. (1989) Crystallization and Preliminary X-ray Diffraction studies of a Complex between Interleukin-2 and p55 component of Interleukin-2 Receptor. Journal of Biological Chemistry 264:12730-12736.

16. Stura E.A., Stanfield R.L., Fieser T.M., Balderas, R.S., Smith, L.R., Lerner R.A., Wilson I.A. (1989) Preliminary Crystallographic Data and Primary Sequence for an Anti-peptide Fab' B13I2 and Its Complex with the C-helix Peptide from Myohemerythrin. Journal of Biological Chemistry 264:15721-15725.

1990

17. Stura E.A., Wilson I.A. (1990) Analytical and Production Seeding Techniques. Methods 1:38 - 49.

18. Rini, J.M., Stanfield, R.L., Stura, E.A., Schulze-Gahmen, U., Wilson, I.A. (1990), in ``Use of X-ray Crystallography in the Design of Antiviral Agents'' Laver, W.G., and Air, G.M., Eds. (Academic Press, San Diego, CA) p. 87.

1991

19. Stura E.A., Wilson I.A. (1991) Applications of the Streak Seeding Technique in protein crystallization. Journal of Crystal Growth. 110:270-282.

20. Stura E.A., Wilson I.A. (1991) Seeding Techniques. In ``Crystallization of Nucleic Acids and Proteins: a practical approach'' (A. Ducruix and G.Giegé eds.) IRL Press, Oxford, pp. 241-254.

21. Stura E.A., Chen P. (1991) Soaking of Crystals. In ``Crystallization of Nucleic Acids and Proteins: a practical approach'' (A. Ducruix and G.Giegé eds.) IRL Press, Oxford, pp. 99-126.

22. Wilson I.A., Rini J.M., Fremont D.H. Fieser G.G., Stura E.A.(1991) Use of X-ray Diffraction analysis of free and antigen complexed Fab fragments in studying the structural basis of antigen-antibody interaction. [Review] Meth. Enz. 203: 270.

23. Wilson I.A. Stanfield R.L. Rini J.M. Arevalo J.H. Schulze-Gahmen U. Fremont D.H. Stura E.A. (1991) Structural aspects of antibodies and antibody-antigen complexes. [Review] Ciba Foundation Symposium. 159:13-28; discussion 28-39.

1992

24. Stura E.A., Chen, P., Wilmot C.M., Arevalo J.H. and Wilson I.A. (1992)Crystallization studies of Unglycosylated Human Recombinant Interleukin-2. Proteins 12:24-30.

25. Stura, E.A., Nemerow, G.R., Wilson, I.A. (1992) Strategies in the crystallization of glycoproteins and protein Complexes. Journal of Crystal Growth 122: 273-285.

26. Ruf, W., Stura, E.A., LaPolla, R.J., Syed, R., Edgington, T.S., Wilson, I.A. (1992) Purification, Sequence and Crystallization of an anti-Tissue Factor Fab and its use for the crystallization of Tissue Factor. Journal of Crystal Growth 122, 253-264.

27. Stura E.A., Stanfield R.L., Rini J.M., Fieser G.G., Silver S., Roguska M., Hincapie L.M., Simmerman H.K.B., Profy A.T., Wilson I.A. (1992) Crystallization, Sequence and Preliminary Crystallographic data for an anti-peptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1. Proteins, 14, 499-508.

28. Rini, J.M., Stanfield, R.L., Stura, E.A., Salinas, P.A., Profy, A.T., Wilson, I.A. (1993) Crystal structure of Neutralizing antibody 50.1 in complex with its V3 loop peptide antigen. Proceedings of the National Academy of Sciences of the United States of America. 90, 6325-6329.

29. Chen, P., Schulze-Gahmen U., Stura E.A., Inglese, J., Johnson, D.L., Marolewski, A., Benkovic S.J., Wilson I.A. (1992) Crystal Structure of Glycinamide Ribonucleotide Transformylase from Escherichia Coli at 3.0 A resolution. A target enzyme for chemotherapy. Journal of Molecular Biology. 227, 283-292.

30. Stura E.A., Matsumura M, Fremont D.H., Saito Y., Peterson P.A., Wilson I.A. (1992) Crystallization of multiple murine major histocompatibility complex class-I H-2K^b with single peptides. Journal of Molecular Biology., 228, 975-982.

31. Fremont D.H, Matsumura M., Stura E.A., Peterson P.A. and Wilson I.A. (1992) Crystal structures of two viral peptides in complex with murine MHC class I H-2K^b. Science, 257, 919-927. Comment in: Science 1992 Aug 14;257(5072):880-881

1993

32. Arevalo J.H., Stura E.A., Taussig M.J., Wilson I.A. (1993) Three-dimensional structure of an anti-steroid Fab' and progesterone Fab' complex. Journal of Molecular Biology. 321, 103-108.

33. Stura E.A., Fieser G.G., Wilson I.A. (1993) Crystallization of Antibodies and Antibody-Antigen Complexes. Immunomethods 3, 164-179.

34. Stura E.A., Kang, A.S, Stefanko, R.S., Calvo, J, Gaarder, K.L, Kaslow D.C., and Satterthwait, A.C. (1993) Crystallographic studies of transmission blocking antimalaria Fab 4B7 with cyclic and linear peptides from the Pfs25 protein of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 49:Suppl.(137)-177.

1994

35. Haynes M.R., Stura E.A., Hilvert, D., Wilson I.A. (1994) Crystallization and Preliminary Structural studies of a chorismate mutase catalytic antibody complexed with a transition state analogue. Proteins, 18,198-200.

36. Haynes M.R., Stura E.A., Hilvert, D., Wilson I.A. (1994) Routes to catalysis: Structure of a catalytic antibody and comparison with its natural counterpart. Science, 263:646-652.

37. Arevalo J.H., Hassig C.A., Stura E.A., Sims M.J., Taussig M.J., Wilson I.A. (1994) Structural analysis of antibody specificity: detailed comparison of five Fab'-steroid complexes. Journal of Molecular Biology, 241:663-690

38. Stura E.A, Satterthwait, A.C, Calvo, J.C, Kaslow, D.C, Wilson, I.A. (1994) Reverse Screening. Acta Cryst. D50 : 448-455.

39. Stura E.A., Kang, A.S., Stefanko, R.S., Calvo, J.C., Kaslow, D.C. and Satterthwait, A.C. (1994) Crystallization, sequence and preliminary crystallographic data for transmission blocking anti-malaria Fab 4B7 with cyclic peptides from the Pfs25 protein of P. falciparum. Acta Cryst. D50 , 535-542.

40. Stura E.A, Satterthwait, A.C, Calvo, J.C, Stefanko, R.S, Langeveld, J.P, Kaslow, D.C (1994) Crystallization of an intact antibody(4B7) against P. falciparum with peptides from the Pfs25 protein antigen. Acta Cryst. D50 , 556-562.

41. Diller T.C., Shaw A, Stura E.A., Vacquier V.D., Stout C.D. (1994) Acid pH crystallization of the basic protein lysin from the spermatozoa of red abalone (Haliotis rufescens). Acta Cryst. D50 : 620-626.

42. Satterthwait A.C., Cabezas E., Calvo J.C., Chen, S.Q., Wu J.X., Wang P.L., Xie Y.L., Stura E.A., Kaslow, D.C. (1995) A peptide mimic as antigen and Immunogen. In Peptides: Biology and Chemistry, Proceedings of the Chinese 1994 Peptide Symposium. Lu, G.S. (ed.) ESCOM, Leiden, the Netherlands, pp. 229.

43. Stura E.A., Kaslow, D.C. and Satterthwait A.C. (1994) Crystallization of a neutralizing malaria immunoglobulin with linear and cyclic peptides In Peptides: Biology and Chemistry, Proceedings of the 13th American Peptide Symposium. Hodges, R., Smith, J.A. (eds.) ESCOM, Leiden, the Netherlands, pp 817.

44. Ghiara J.B., Stura E.A., Stanfield R.L. Profy A.T., Wilson I.A. (1994) Crystal Structure of the Principle Neutralizing Site of HIV-1. Science 264: 82-85.

45. Churchill M.E. Stura E.A. Pinilla C. Appel J.R. Houghten R.A. Kono D.H. Balderas R.S. Fieser G.G. Schulze-Gahmen U. Wilson I.A. (1994) Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen. Journal of Molecular Biology. 241, 534-556.

46. Wilson I.A., Stanfield R.L., Jewell D.A., Ghiara J.B., Fremont D.H, Stura E.A. (1994) Immune recognition of viral antigens. Infectious Agents and Disease 3,155-162.

47. Shalk I.J., Stura E.A., Matteson J., Wilson, I.A., Balch E.E. (1994) Crystallization and preliminary crystallographic data for Rab guanine nucleotide dissociation inhibitor (RabGDI) from Bovine Brain. Journal of Molecular Biology, 244, 469-473.

1995

48. Fremont D.H, Stura E.A., Matsumura M., Peterson P.A. and Wilson I.A. (1995) Crystal structure of an H-2K^b-ovalbumin peptide complex reveals interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proceedings of the National Academy of Sciences of the United States of America. 92:2479-2483.

49.Wien M.W, Filman, D.J, Stura, E.A, Guillot, S, Delpeyroux, Crainic, R, Hogle, M. (1995) Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope. Nature, Structural Biology 2, 232-243.

50. Stura E.A, Ghosh S, Garcia-Junceda E, Chen L, Wong C-H, Wilson I.A. (1995) Crystallization and preliminary crystallographic data for class I Deoxy-5-Phosphate aldolase from Escherichia coli: An Application of Reverse Screening. Proteins, 22, 67-72.

51. Klein C. Chen P. Arevalo J.H. Stura E.A. Marolewski A. Warren M.S. Benkovic S.J. Wilson I.A. (1995) Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 Å resolution. Journal of Molecular Biology. 249. 53-75.

1996

52. Livnah, O., Stura, E. A., Johnson, D.L., Mulcahy, L.S., Wrighton, N.C., Dower, W.J., Jolliffe, L.K. and Wilson I. A. (1996) Functional mimicry of a protein hormoneby a peptide agonist: The EPO receptor at 2.8 Å. Science 273:464-471.

53. Shalk, I., Zeng, K., Wu, S.-K., Stura, E.A., Matteson J., Huang M., Tandon, A., Wilson, I.A. and Balch, W.E. (1996) Structure and mutational analysis of Rab GDP-dissociation inhibitor. Nature 381:42-48.

54. Stura, E. A., Ruf, W., Wilson I. A. (1996) Crystallization and preliminary crystallographic data for a ternary complex between tissue factor, factor VIIa and a BPTI-derived inhibitor. J. Cryst. Growth 168:260-269.

55. Prasad, G.S., Stura, E.A., McRee D.E., Stout, C. D. and Elder, J. H. (1996) Crystal Structure of FIV dUTP pyrophosphatase. Protein Science 5:2429-2437.

56. Prasad, G.S., McRee D.E., Stura, E.A., Levitt, D.G. Lee, H.C. and Stout, C. D. (1996) Crystal structure of Aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38. Nature Strutural Biology 3:957-964 57. Satterthwait, A.C., Cabezas, E., Calvo, J.C., Wu, J.X., Chen, S.Q., Kaslow, D.C., Livnah, O., and Stura, E.A., (1996) Constrained Synthetic Peptide Vaccines in "Pep tides: Chemistry, Structure & Biology" Proceedings of the 14th American Peptide Symposium. Kaumaya P.T.P., Hodges, R.S. eds. pp. 772-773.

58. Reference 70 in: Science 1996 Oct 11;274(5285):209-219 An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex.

1997

59. He. M., Gani, M., Livnah, O., Stura, E.A., Beale, D., Coley. J., Wilson. I.A., Taussig, M.J. (1997) Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910) Immunology 90: 632-639.

60. Zeng, Z., Castaño, A.R., Segelke, B.W., Stura E.A., Peterson P.A. and Wilson I.A. (1997) Crystal Structure of Mouse CD1: An MHC-Like Fold with a Large Hydrophobic Binding Groove. Science 277:339-345

1998 and in preparation

61. DiScipio R.G. and Stura, E.A. (1997) Crystallization of human complement component C5. Acta Cryst. D (in preparation).

62. Stura, E.A., Livnah, O., Johnson, D., Jolliffe, L. K., Mulcahy, L.S., Wilson, I.A., and Satterthwait, A.C. (1997) Design of a peptide for the crystallization of the erythropoietin receptor: Preliminary crystallographic report. Acta Cryst D. (Prepared)

63. Stura, E. A., Livnah, O., Johnson, D.L., Mulcahy, L.S., Wrighton, N.C., Dower, W.J., Jolliffe, L.K. and Wilson I. A. (1997) Crystallization of an active complex between the extracellular domain of the human erythropoietin receptor and an agonist peptide. Acta Cryst. D. (in preparation).

64. Stura, E.A., Diller, T.C., Prasad, G.S., Hasselkus-Light, C., Laco, G.S., Stout, C.D. and Elder, J.H. (1997) Crystallization and preliminary crystallographic studies of Feline Immunodeficiency Virus dUTPase in the absence and in complex with dUMP. FEBS Lett. (In Preparation)

65. Livnah, O., Wang, P.L., Wilson I.A., Kaslow, D.C., Satterthwait, A.C. and Stura, E.A., (1996) Anti-malaria transmission blocking: Crystal structures of Fab 4B7 unbound and complexed with cyclic peptides. Science. (In preparation)

66. Stanfield, R.L., Cabezas, E., Satterthwait, A.C., Stura, E.A., Profy, A.,Wilson I.A. (1996) Structures of linear and cyclic peptides in complex with an HIV-1 neutralizing Fab. (In preparation)

67. Heine, A., Stura, E.A., Fieser, G.G., Rosenblum, J., Cravatt, B., Lerner R.A., Wilson I.A. (1996) Crystallization, sequence and preliminary structural studies structural studies of a syn elimination catalytic antibody obtained by a new approach in Fab purification (In preparation)

68. Stura E.A. (1997) Seeding Techniques. In "Crystallization of Nucleic Acids and Proteins: a practical approach" Second Edition (A. Ducruix and G.Giegé eds.) IRL Press, Oxford, in revision.

69. Stura E.A. (1997) Soaking of Crystals. In "Crystallization of Nucleic Acids and Pro teins: a practical approach" Second Edition (A. Ducruix and G.Giegé eds.) IRL Press, Oxford, in revision.

Last Modified: August 16, 1997